Skip to content

Analysis of Proinflammatory Factors in the Synovial Fluid In Patients With Rotator Cuff Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01069224
Enrollment
40
Registered
2010-02-17
Start date
2010-03-31
Completion date
2011-03-31
Last updated
2010-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Disease

Keywords

rotator cuff, synovial fluid, proinflammatory cytokines

Brief summary

Role of proinflammatory factors in Patients with Rotator Cuff Disease Objective: To measure the levels of various cytokines and metalloproteases in patients with rotator cuff disease, and control group and to determine the correlations among them.

Detailed description

We hypothesize that cytokines and MMP's level will be significantly higher in patients with RC pathology than in control group and will be related to the time frame since injury (i.e. - higher levels as close to the injury). In addition we will examine possible relation of those levels to the pain curve by using Visual Analogue Scale.

Interventions

None listed

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Ability to understand and accept the trial procedures and to sign an informed consent form in accordance with national legislation. 2. Patients between age 18-65 scheduled for a surgery in a Shoulder unit 3. Patients suffering from Rotator Cuff Disease 4. Patients suffering from any noninflammatory shoulder condition which requires surgical intervention

Exclusion criteria

1. Revision rotator cuff repair 2. Recurrent shoulder surgery 3. Psychiatric illness 4. Inflammatory condition. 5. Current use of anti-inflammatory drugs. 6. Previous or current shoulder infection.

Design outcomes

Primary

MeasureTime frame
cytokines and MMP's levels in patients with RC pathology and in control group12 month

Secondary

MeasureTime frame
Levels of pain curve by using Visual Analogue Scale12 month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026